BridgeMD
New treatment option for Autism
Official title "Opt-In" Early Intervention Program for Children Waiting to Receive an Autism Diagnosis
ClinicalTrials.gov ID: NCT07081724
What this study is testing
- What it's testing
- A growing body of literature documents the benefits of parent-mediated interventions for autism starting early in life . However, the median age of diagnosis in the US continues to be 49 months.
- Time commitment: about 6 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 48
You may be able to join if
- age between 16-48 months,
- parental consent
- being on a waitlist to receive a formal diagnostic evaluation at the time of parent consent due to autism concerns
- parents speak English
- an initial score of 8 or greater or Follow-Up score of 2 or greater on the Modified Checklist for Autism in Toddlers, Revised, with Follow-Up...
You likely can't join if
- having already received a formal diagnosis of autism
- enrollment in early intervention programs delivering more than 5 h per week of evidence-based autism-specific interventions at the time of consent
- child has a gestational age less than 36 weeks associated with a birth weight less than 2500 g
- the child is not yet walking, or has severe hearing and/or vision impairment that is uncorrected with aids, or known neurological disorder or genetic...
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 16 months to 48 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.